乳腺癌合并小脑原发占位极易误诊为乳腺癌脑转移病例一例及文献综述

超 张()
志琴 林(赣南医科大学第一附属医院乳腺诊疗中心，中国;)
嘉莹 郭(赣南医科大学第一临床医学院，中国;)
辉阳 唐(赣南医科大学第一临床医学院，中国;)
梅芳 李(赣南医科大学第一附属医院乳腺诊疗中心，中国;)

摘要

乳腺癌脑转移发生率约为10%~15%，多数发生于Her-2阳性和三阴性乳腺癌，颅内病灶以大脑半球为主[1,2]。血管母细胞瘤（hemangioblastoma, HB）属于罕见颅内良性肿瘤，约占所有颅内肿瘤的1%-2.5% ，好发于小脑，因影像学表现多样，易与转移瘤混淆[3]。由于二者治疗策略及预后差异显著，误诊将导致过度治疗。本文报道1例左乳浸润性癌伴小脑占位初诊为脑转移、术后病理颠覆性诊断为血管母细胞瘤的病例，旨在强调多学科协作（MDT）模式对乳腺癌合并颅内孤立病灶的诊断价值，探讨乳腺癌患者合并罕见颅内病变的鉴别要点，为减少临床误诊提供参考。

关键词

乳腺肿瘤；血管母细胞瘤；误诊；脑转移瘤；多学科协作

参考

Lin N U, Amiri-Kordestani L, Palmieri D, et al. CNS metastases in breast cancer: old challenge, new frontiers[J]. Clinical Cancer Research, 2013, 19(23): 6404~6418.

Martin A M, Cagney D N, Catalano P J, et al. Brain metastases in newly diagnosed breast cancer: a population-based study[J]. JAMA Oncology, 2017, 3(8): 1069~1077.

Louis D N, Perry A, Wesseling P, et al. The 2021 who classification of tumors of the central nervous system: a summary[J]. Neuro-Oncology, 2021, 23(8): 1231~1251.

Kreatsoulas D C, Lonser R R. Spinal cord hemangioblastomas in von hippel–lindau disease[J]. Neuro-Oncology Advances, 2024, 6(Supplement_3): iii66~iii72.

Ho V B, Smirniotopoulos J G, Murphy F M, et al. Radiologic-pathologic correlation: hemangioblastoma[J]. AJNR: American Journal of Neuroradiology, 1992, 13(5): 1343.

Osborn A G. Osborn’s brain: imaging, pathology, and anatomy[J/OL]. (No Title), 2013[2025–08–06]. https://cir.nii.ac.jp/crid/ 1130282269802530304.

Gläsker S, Vergauwen E, Koch C A, et al. Von hippel-lindau disease: current challenges and future prospects[J]. OncoTargets and Therapy, 2020, Volume 13: 5669~5690. DOI:10.2147/OTT.S190753.

Aldape K, Nejad R, Louis D N, et al. Integrating molecular markers into the world health organization classification of cns tumors: a survey of the neuro-oncology community[J]. Neuro-Oncology, 2017, 19(3): 336~344.

Gläsker S, Bender B U, Apel T W, et al. The impact of molecular genetic analysis of thevhl gene in patients with haemangioblastomas of the central nervous system[J]. Journal of Neurology, Neurosurgery and Psychiatry, 1999, 67(6): 758~762.

Ling J Y, Stephenson K A, Romanuik T L, et al. Detection of vhl variant on multigene panel testing for hereditary breast cancer: implications for genetic counselling[J]. Cancer Genetics, 2025, 296–297: 150~153. DOI:10.1016/j.cancergen.2025.07.003.

Tarantino R, Isidori A, Raco A, et al. Supratentorial hemangioblastoma in a patient with breast cancer. a case report[J]. Journal of Neurosurgical Sciences, 2000, 44(3): 137~139.

McLaughlin N, Kelly D F, Prevedello D M, et al. Hemostasis management during completely endoscopic removal of a highly vascular intraparenchymal brain tumor: technique assessment[J]. Journal of Neurological Surgery. Part A, Central European Neurosurgery, 2014, 75(1): 42~47. DOI:10.1055/s-0032-1325631.

She D, Yang X, Xing Z, et al. Differentiating hemangioblastomas from brain metastases using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted mr imaging[J]. American Journal of Neuroradiology, 2016, 37(10): 1844~1850.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v8i9.31962